ATE195065T1 - Biologisch abbaubarer sklerastopfen - Google Patents

Biologisch abbaubarer sklerastopfen

Info

Publication number
ATE195065T1
ATE195065T1 AT94907661T AT94907661T ATE195065T1 AT E195065 T1 ATE195065 T1 AT E195065T1 AT 94907661 T AT94907661 T AT 94907661T AT 94907661 T AT94907661 T AT 94907661T AT E195065 T1 ATE195065 T1 AT E195065T1
Authority
AT
Austria
Prior art keywords
drug
sclera
surgical operation
vitreous body
plug
Prior art date
Application number
AT94907661T
Other languages
English (en)
Inventor
Yuichiro Ogura
Yoshito Ikada
Original Assignee
Santen Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Santen Pharmaceutical Co Ltd filed Critical Santen Pharmaceutical Co Ltd
Application granted granted Critical
Publication of ATE195065T1 publication Critical patent/ATE195065T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F9/00—Methods or devices for treatment of the eyes; Devices for putting-in contact lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M31/00—Devices for introducing or retaining media, e.g. remedies, in cavities of the body
    • A61M31/002—Devices for releasing a drug at a continuous and controlled rate for a prolonged period of time
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F9/00—Methods or devices for treatment of the eyes; Devices for putting-in contact lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
    • A61F9/0008—Introducing ophthalmic products into the ocular cavity or retaining products therein
    • A61F9/0017—Introducing ophthalmic products into the ocular cavity or retaining products therein implantable in, or in contact with, the eye, e.g. ocular inserts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F9/00—Methods or devices for treatment of the eyes; Devices for putting-in contact lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
    • A61F9/007—Methods or devices for eye surgery
    • A61F9/00781—Apparatus for modifying intraocular pressure, e.g. for glaucoma treatment
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A61K9/0051—Ocular inserts, ocular implants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/0057—Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
    • A61B2017/00004—(bio)absorbable, (bio)resorbable, resorptive

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Ophthalmology & Optometry (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Vascular Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Anesthesiology (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Surgery (AREA)
  • Neurosurgery (AREA)
  • Dermatology (AREA)
  • Materials For Medical Uses (AREA)
  • Medicinal Preparation (AREA)
  • Prostheses (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
AT94907661T 1993-02-26 1994-02-23 Biologisch abbaubarer sklerastopfen ATE195065T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP6281493 1993-02-26
JP6945793 1993-03-04
PCT/JP1994/000273 WO1994018921A1 (fr) 1993-02-26 1994-02-23 Bouchon de sclerotique biodegradable

Publications (1)

Publication Number Publication Date
ATE195065T1 true ATE195065T1 (de) 2000-08-15

Family

ID=26403867

Family Applications (1)

Application Number Title Priority Date Filing Date
AT94907661T ATE195065T1 (de) 1993-02-26 1994-02-23 Biologisch abbaubarer sklerastopfen

Country Status (12)

Country Link
EP (1) EP0654256B1 (de)
KR (1) KR100313268B1 (de)
AT (1) ATE195065T1 (de)
CA (1) CA2118515A1 (de)
DE (1) DE69425411T2 (de)
DK (1) DK0654256T3 (de)
ES (1) ES2150487T3 (de)
FI (1) FI945014A (de)
GR (1) GR3034526T3 (de)
NO (1) NO303665B1 (de)
PT (1) PT654256E (de)
WO (1) WO1994018921A1 (de)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999001156A1 (fr) * 1997-07-02 1999-01-14 Santen Pharmaceutical Co., Ltd. Bouchons scleraux d'acide polylactique
US6991650B2 (en) 1997-10-08 2006-01-31 Refocus Ocular, Inc. Scleral expansion device having duck bill
US7008396B1 (en) 1999-09-03 2006-03-07 Restorvision, Inc. Ophthalmic device and method of manufacture and use
US6375642B1 (en) * 2000-02-15 2002-04-23 Grieshaber & Co. Ag Schaffhausen Method of and device for improving a drainage of aqueous humor within the eye
EP3167872B1 (de) * 2000-07-05 2020-10-14 Allergan, Inc. Verfahren zur behandlung von entzündungsbedingten zuständen der augen
US6726918B1 (en) * 2000-07-05 2004-04-27 Oculex Pharmaceuticals, Inc. Methods for treating inflammation-mediated conditions of the eye
AU2002236495B2 (en) 2000-11-29 2006-05-11 Allergan, Inc. Intraocular implants for preventing transplant rejection in the eye
US20050048099A1 (en) 2003-01-09 2005-03-03 Allergan, Inc. Ocular implant made by a double extrusion process
US20040137059A1 (en) 2003-01-09 2004-07-15 Thierry Nivaggioli Biodegradable ocular implant
KR20060129246A (ko) 2003-12-05 2006-12-15 컴파운드 쎄라퓨틱스, 인크. 타입 2 혈관 내피 성장 인자 수용체의 억제제
US8685435B2 (en) 2004-04-30 2014-04-01 Allergan, Inc. Extended release biodegradable ocular implants
US8802128B2 (en) 2006-06-23 2014-08-12 Allergan, Inc. Steroid-containing sustained release intraocular implants and related methods
US8911496B2 (en) 2006-07-11 2014-12-16 Refocus Group, Inc. Scleral prosthesis for treating presbyopia and other eye disorders and related devices and methods
MX2009000378A (es) 2006-07-11 2009-08-12 Refocus Group Inc Protesis escleral para tratar presbiopia y otros trastornos del ojo y dispositivos y metodos relacionados.
CA2670471A1 (en) 2006-11-22 2008-06-05 Adnexus, A Bristol-Myers Squibb R&D Company (A Delaware Corporation) Targeted therapeutics based on engineered proteins for tyrosine kinases receptors, including igf-ir
US8969415B2 (en) 2006-12-01 2015-03-03 Allergan, Inc. Intraocular drug delivery systems
US8231892B2 (en) 2007-05-24 2012-07-31 Allergan, Inc. Biodegradable drug delivery system
JP2011517314A (ja) 2008-02-14 2011-06-02 ブリストル−マイヤーズ スクイブ カンパニー Ｅｇｆｒに結合する操作されたタンパク質に基づく標的化された治療薬
EP2799448A1 (de) 2008-05-22 2014-11-05 Bristol-Myers Squibb Company Polyvalente Proteine mit Fibronectin-Gerüstdomänen
TWI496582B (zh) 2008-11-24 2015-08-21 必治妥美雅史谷比公司 雙重專一性之ｅｇｆｒ／ｉｇｆｉｒ結合分子
JP6023703B2 (ja) 2010-05-26 2016-11-09 ブリストル−マイヤーズ スクイブ カンパニーＢｒｉｓｔｏｌ−Ｍｙｅｒｓ Ｓｑｕｉｂｂ Ｃｏｍｐａｎｙ 改善された安定性を有するフィブロネクチンをベースとする足場タンパク質
KR101750651B1 (ko) * 2016-01-28 2017-06-23 동국대학교 산학협력단 약물 잔류 방지능 및 재충전 기능을 갖는 안구 내 약물 주입 장치
CN106667656A (zh) * 2016-06-30 2017-05-17 广州聚明生物科技有限公司 生物可降解泪道栓及其制备方法和应用
EP3518828A4 (de) 2016-10-03 2020-06-17 California Institute of Technology Radiolumineszierende fototherapievorrichtung
WO2019152526A1 (en) 2018-01-31 2019-08-08 California Institute Of Technology Controllable ocular phototherapy

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4439198A (en) * 1981-07-09 1984-03-27 University Of Illinois Foundation Biodegradable ocular insert for controlled delivery of ophthalmic medication
US4634418A (en) * 1984-04-06 1987-01-06 Binder Perry S Hydrogel seton
US4863457A (en) * 1986-11-24 1989-09-05 Lee David A Drug delivery device
US5098443A (en) * 1989-03-23 1992-03-24 University Of Miami Method of implanting intraocular and intraorbital implantable devices for the controlled release of pharmacological agents
US5164188A (en) * 1989-11-22 1992-11-17 Visionex, Inc. Biodegradable ocular implants
KR0185215B1 (ko) * 1990-11-30 1999-05-01 요시다 쇼오지 서방성 안구삽입용 약제
JPH04364857A (ja) * 1991-06-12 1992-12-17 Asahi Chem Ind Co Ltd 涙道せき止め用ロッド

Also Published As

Publication number Publication date
DK0654256T3 (da) 2000-12-18
EP0654256A4 (de) 1995-01-04
NO944060D0 (no) 1994-10-25
NO944060L (no) 1994-10-25
EP0654256B1 (de) 2000-08-02
ES2150487T3 (es) 2000-12-01
GR3034526T3 (en) 2000-12-29
CA2118515A1 (en) 1994-02-23
PT654256E (pt) 2000-12-29
FI945014A0 (fi) 1994-10-25
DE69425411T2 (de) 2001-02-08
FI945014A (fi) 1994-10-25
EP0654256A1 (de) 1995-05-24
DE69425411D1 (de) 2000-09-07
WO1994018921A1 (fr) 1994-09-01
KR100313268B1 (ko) 2002-11-22
NO303665B1 (no) 1998-08-17
KR950701209A (ko) 1995-03-23

Similar Documents

Publication Publication Date Title
ATE195065T1 (de) Biologisch abbaubarer sklerastopfen
CA1190001A (en) Posterior chamber lens
BRPI0406692A (pt) Implante ocular biodegradável
SE8403090L (sv) Gel for anvendning som glaskroppssubstitut
CA2368335A1 (en) Inflatable device and method for treating glaucoma
DE69422707D1 (de) Verfahren zur verhinderung der trübung der hinteren linsenkapsel
DE69602412T2 (de) Ophthalmische Zubereitung zur Behandlung oder Prävention von trockenem Auge und Krankheiten, die dadurch verursacht werden, enthaltend 12-Sulfodehydroabietsäure
ATE343983T1 (de) Ophthalmologisches implantat
DK0403360T3 (da) Anvendelse af phenylethanolaminer til fremstilling af et lægemiddel mod øjenlidelser
FR2757064B1 (fr) Lentille intraoculaire contenant un medicament relargable
SE9101840D0 (sv) New medicinal use
DK0410749T3 (da) Anthocyanidiner til behandling af ophthalmiske sygdomme
DE69100171D1 (de) Synergistische kombination zur ophthalmischen verwendung.
Bowman et al. Noninvasive repositioning of a posterior chamber intraocular lens following pupillary capture
CA2396130A1 (en) Preparation of irrigating solution for ocular surgery
AU643772B2 (en) Use of hexetidine or its derivatives or salts for the preparation of a pharmaceutical composition for ophthalmological use
SU1138155A1 (ru) Способ кератопротезировани
SU1597187A1 (ru) Способ удалени дра хрусталика и хрусталиковых масс из передней камеры глаза
Mel'nikov et al. Experience in laser treatment of primary glaucoma
Scheie et al. Choice of a Miotic Agent Following Retrobulbar Anesthesia
RU2003118574A (ru) Дренаж для лечения неоваскулярной глаукомы и способ лечения неоваскулярной глаукомы
LG THE NEWER TECHNIQUES IN RETINAL DETACHMENT SURGERY. INDICATIONS FOR THE NEWER METHOD.
UA19588A (uk) Спосіб екстракції травматичhої катаракти з пошкоджеhhям задhьої капсули кришталика
Turner ART. V.--An Account of an Operation for the removal of a Congenital Cataract of the Capsulo-lenticular variety.
UA37512A (uk) Спосіб екстракції катаракти

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee